Literature DB >> 16874749

Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis.

César Sánchez1, Alfredo F Braña, Carmen Méndez, José A Salas.   

Abstract

The biosynthetic pathways for violacein and for indolocarbazoles (rebeccamycin, staurosporine) include a decarboxylative fusion of two tryptophan units. However, in the case of violacein, one of the tryptophans experiences an unusual 1-->2 shift of the indole ring. The violacein biosynthetic gene cluster was previously reported to consist of four genes, vioABCD. Here we studied the violacein pathway through expression of vio genes in Escherichia coli and Streptomyces albus. A pair of genes (vioAB), responsible for the earliest steps in violacein biosynthesis, was functionally equivalent to the homologous pair in the indolocarbazole pathway (rebOD), directing the formation of chromopyrrolic acid. However, chromopyrrolic acid appeared to be a shunt product, not a violacein intermediate. In addition to vioABCD, a fifth gene (vioE) was essential for violacein biosynthesis, specifically for production of the characteristic 1-->2 shift of the indole ring. We also report new findings on the roles played by the VioC and VioD oxygenases, and on the origin of violacein derivatives of the chromoviridans type.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874749     DOI: 10.1002/cbic.200600029

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  32 in total

1.  Expression, crystallization and preliminary crystallographic data analysis of VioD, a hydroxylase in the violacein-biosynthesis pathway.

Authors:  Tingting Ran; Mengxiao Gao; Qiaoe Wei; Jianhua He; Lin Tang; Weiwu Wang; Dongqing Xu
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

Review 2.  Total (bio)synthesis: strategies of nature and of chemists.

Authors:  Alexandra A Roberts; Katherine S Ryan; Bradley S Moore; Tobias A M Gulder
Journal:  Top Curr Chem       Date:  2010

3.  The violacein biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins.

Authors:  Katherine S Ryan; Carl J Balibar; Kaitlyn E Turo; Christopher T Walsh; Catherine L Drennan
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

4.  Purple-pigmented violacein-producing Duganella spp. inhabit the rhizosphere of wild and cultivated olives in southern Spain.

Authors:  Sergio Aranda; Miguel Montes-Borrego; Blanca B Landa
Journal:  Microb Ecol       Date:  2011-03-22       Impact factor: 4.552

5.  Antifungal Bacteria on Woodland Salamander Skin Exhibit High Taxonomic Diversity and Geographic Variability.

Authors:  Carly R Muletz-Wolz; Graziella V DiRenzo; Stephanie A Yarwood; Evan H Campbell Grant; Robert C Fleischer; Karen R Lips
Journal:  Appl Environ Microbiol       Date:  2017-04-17       Impact factor: 4.792

Review 6.  Therapeutic applications of bacterial pigments: a review of current status and future opportunities.

Authors:  Muhammad Numan; Samina Bashir; Roqayya Mumtaz; Sibgha Tayyab; Najeeb Ur Rehman; Abdul Latif Khan; Zabta Khan Shinwari; Ahmed Al-Harrasi
Journal:  3 Biotech       Date:  2018-04-04       Impact factor: 2.406

7.  Total synthesis of lycogarubin C and lycogalic acid.

Authors:  James S Oakdale; Dale L Boger
Journal:  Org Lett       Date:  2010-03-05       Impact factor: 6.005

8.  Biosynthesis of Violacein, Structure and Function of l-Tryptophan Oxidase VioA from Chromobacterium violaceum.

Authors:  Janis J Füller; René Röpke; Joern Krausze; Kim E Rennhack; Nils P Daniel; Wulf Blankenfeldt; Stefan Schulz; Dieter Jahn; Jürgen Moser
Journal:  J Biol Chem       Date:  2016-07-27       Impact factor: 5.157

9.  Divergent pathways in the biosynthesis of bisindole natural products.

Authors:  Katherine S Ryan; Catherine L Drennan
Journal:  Chem Biol       Date:  2009-04-24

10.  Violacein-producing Collimonas sp. from the sea surface microlayer of costal waters in Trøndelag, Norway.

Authors:  Sigrid Hakvåg; Espen Fjaervik; Geir Klinkenberg; Sven Even F Borgos; Kjell D Josefsen; Trond E Ellingsen; Sergey B Zotchev
Journal:  Mar Drugs       Date:  2009-11-12       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.